The projected sales for systemic hormonal preparations (excluding sex hormones and insulins) in Belgium remain essentially flat from 2024 to 2028, with values hovering around $12.1 USD per capita in 2024 and dropping slightly to $12 USD per capita from 2025 onwards.
-1.0% (2024-2025), 0% (2025-2026), 0% (2026-2027), 0% (2027-2028)
-0.33% over the next 5 years
Moving forward, key trends to monitor include advancements in alternative treatments, potential regulatory changes, and demographic shifts which may impact the demand for systemic hormonal preparations. Keeping an eye on these factors will be crucial for understanding potential market dynamics.
